Article
Reovirus Reassortants Reveal Context-Dependent Oncolytic Phenotypes Across Epithelial Cancer Cell Lines.
Viral immunology - 1 Sept 2026
Hutchinson J Ryder, Carter Owen M, Dagli Charlotte V, Rivera-Serrano Efraín E
Abstract excerpt
Mammalian reoviruses are promising oncolytic agents, but most preclinical and clinical work has focused on the type 3 Dearing (T3D) prototype, potentially underestimating the therapeutic relevance of broader reovirus genetic diversity. Because reoviruses possess a segmented double-stranded RNA genome, reassortment can generate progeny with novel combinations of traits influencing infectivity, replication, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
